Travoprost Patent Expiration
Travoprost was first introduced by Alcon Pharmaceuticals Ltd
Travoprost Patents
Given below is the list of patents protecting Travoprost, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Idose Tr | US10206813 | Implants with controlled drug delivery features and methods of using same | Oct 17, 2030 | Glaukos |
| Idose Tr | US11426306 | Implants with controlled drug delivery features and methods of using same | Oct 17, 2030 | Glaukos |
| Travatan Z | US8268299 | Self preserved aqueous pharmaceutical compositions | Oct 13, 2029 | Sandoz |
| Izba | US8178582 | Pharmaceutical compositions having desirable bioavailability | Oct 10, 2029 | Novartis |
| Izba | US8722735 | Pharmaceutical compositions having desirable bioavailability | Oct 10, 2029 | Novartis |
| Izba | US8754123 | Pharmaceutical compositions having desirable bioavailability | May 19, 2029 | Novartis |
| Izba | US9144561 | Pharmaceutical compositions having desirable bioavailability | Mar 13, 2029 | Novartis |
| Travatan Z | US8323630 | Self-preserved aqueous pharmaceutical compositions | Sep 20, 2027 | Sandoz |
| Travatan Z | US8388941 | Self preserved aqueous pharmaceutical compositions | Sep 20, 2027 | Sandoz |
| Travatan | US5631287 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US5849792 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US6011062 | Storage-stable prostaglandin compositions |
Dec 22, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan | US5889052 | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Dec 02, 2014
(Expired) | Alcon Pharms Ltd |
| Travatan Z | US5889052 | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Dec 02, 2014
(Expired) | Sandoz |
| Travatan | US5510383 | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
Aug 03, 2013
(Expired) | Alcon Pharms Ltd |
| Travatan Z | US5510383 | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
Aug 03, 2013
(Expired) | Sandoz |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Travoprost's patents.
Latest Legal Activities on Travoprost's Patents
Given below is the list recent legal activities going on the following patents of Travoprost.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 May, 2024 | US8323630(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Mar, 2024 | US8268299(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Aug, 2020 | US8388941 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 May, 2020 | US8323630(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Mar, 2020 | US8268299(Litigated) |
| Review Certificate Mailed | 11 Jun, 2019 | US8268299(Litigated) |
| Review Certificate | 02 May, 2019 | US8268299(Litigated) |
| Termination or Final Written Decision | 20 Sep, 2018 | US8268299(Litigated) |
| Request for Trial Granted Critical | 22 Sep, 2017 | US8268299(Litigated) |
| Petition Entered | 28 Mar, 2017 | US8268299(Litigated) |
Travoprost's Family Patents
Explore Our Curated Drug Screens
Travoprost Generic API Manufacturers
Several generic applications have been filed for Travoprost. The first generic version for Travoprost was by Chartwell Rx Sciences Llc and was approved on Mar 1, 2013. And the latest generic version is by Somerset Therapeutics Llc and was approved on Sep 23, 2024.
Given below is the list of companies who have filed for Travoprost generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT1 | Dec 20, 2019 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. APOTEX
Apotex Inc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | Jul 10, 2015 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004%
(reference standard) | solution/drops | Prescription | OPHTHALMIC | AT1 | Mar 1, 2013 |
4. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | Jul 12, 2024 |
5. LUPIN LTD
Lupin Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | May 3, 2024 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | Mar 19, 2021 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
7. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | Jul 7, 2017 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
8. SOMERSET THERAPS LLC
Somerset Therapeutics Llc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004% | solution/drops | Prescription | OPHTHALMIC | AT | Sep 23, 2024 |